Summary
For Year 2026-27, Sheel Biotech reports the following shareholding: Total Promoters at 72.29%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 9.49%, and Retail at 18.22%. This breakdown provides a quick snapshot of ownership distribution for Sheel Biotech in 2026-27.
Sheel Biotech FAQs
As of 04-2026, the promoter shareholding in Sheel Biotech stands at 72.29% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Sheel Biotech is 0% and 9.49% respectively.
The retail shareholding of the Sheel Biotech is 18.22%.
Changes in shareholding patterns of Sheel Biotech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Sheel Biotech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
